TY - JOUR
T1 - Development and structural characterization of an engineered multi-copper oxidase reporter of protein-protein interactions
AU - Sana, Barindra
AU - Chee, Sharon M.Q.
AU - Wongsantichon, Jantana
AU - Raghavan, Sarada
AU - Robinson, Robert C.
AU - Ghadessy, Farid J.
N1 - Funding Information:
This work was supported by the Agency for Science Technology and Research (A*STAR), Singapore. The authors declare that they have no conflicts of interest with the contents of this article. Author’s Choice—Final version open access under the terms of the Creative Commons CC-BY license. The atomic coordinates and structure factors (codes 6IM7, 6IM8, and 6IM9) have been deposited in the Protein Data Bank (http://wwpdb.org/). This article contains Figs. S1 and S2. 1To whom correspondence should be addressed. E-mail: fghadessy@ p53Lab.a-star.edu.sg.
Publisher Copyright:
© 2019 Sana et al.
PY - 2019/4/26
Y1 - 2019/4/26
N2 - Protein-protein interactions (PPIs) are ubiquitous in almost all biological processes and are often corrupted in diseased states. A detailed understanding of PPIs is therefore key to understanding cellular physiology and can yield attractive therapeutic targets. Here, we describe the development and structural characterization of novel Escherichia coli CueO multi-copper oxidase variants engineered to recapitulate protein-protein interactions with commensurate modulation of their enzymatic activities. The fully integrated single-protein sensors were developed through modular grafting of ligand-specific peptides into a highly compliant and flexible methionine-rich loop of CueO. Sensitive detection of diverse ligand classes exemplified by antibodies, an E3 ligase, MDM2 proto-oncogene (MDM2), and protease (SplB from Staphylococcus aureus) was achieved in a simple mix and measure homogeneous format with visually observable colorimetric readouts. Therapeutic antagonism of MDM2 bysmall molecules and peptides in clinical development for treatment of cancer patients was assayed using the MDM2-binding CueO enzyme. Structural characterization of the free and MDM2-bound CueO variant provided functional insight into signal-transducing mechanisms of the engineered enzymes and highlighted the robustness of CueO as a stable and compliant scaffold for multiple applications.
AB - Protein-protein interactions (PPIs) are ubiquitous in almost all biological processes and are often corrupted in diseased states. A detailed understanding of PPIs is therefore key to understanding cellular physiology and can yield attractive therapeutic targets. Here, we describe the development and structural characterization of novel Escherichia coli CueO multi-copper oxidase variants engineered to recapitulate protein-protein interactions with commensurate modulation of their enzymatic activities. The fully integrated single-protein sensors were developed through modular grafting of ligand-specific peptides into a highly compliant and flexible methionine-rich loop of CueO. Sensitive detection of diverse ligand classes exemplified by antibodies, an E3 ligase, MDM2 proto-oncogene (MDM2), and protease (SplB from Staphylococcus aureus) was achieved in a simple mix and measure homogeneous format with visually observable colorimetric readouts. Therapeutic antagonism of MDM2 bysmall molecules and peptides in clinical development for treatment of cancer patients was assayed using the MDM2-binding CueO enzyme. Structural characterization of the free and MDM2-bound CueO variant provided functional insight into signal-transducing mechanisms of the engineered enzymes and highlighted the robustness of CueO as a stable and compliant scaffold for multiple applications.
UR - http://www.scopus.com/inward/record.url?scp=85065090964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065090964&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA118.007141
DO - 10.1074/jbc.RA118.007141
M3 - Article
C2 - 30770473
AN - SCOPUS:85065090964
SN - 0021-9258
VL - 294
SP - 7002
EP - 7012
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 17
ER -